Biden touts Pfizer booster access after CDC boss overrules panel

The Centers for Disease Control and Prevention director, Rochelle Walensky, issued a statement advising that booster shots could be given to people with the Pfizer vaccine 6 months after second shot

pfizer vaccine
Josh Wingrove and Jenny Leonard | Bloomberg
2 min read Last Updated : Sep 24 2021 | 8:09 PM IST
President Joe Biden said that most Americans with the Pfizer Inc.-BioNTech SE Covid-19 vaccine will be able to get a booster shot, after one of his top health officials overruled an advisory panel to expand eligibility.

“The majority of Americans who were fully vaccinated with the Pfizer vaccine are now able to receive the booster shot six months after they’ve received their second shot,” Biden said Friday at the White House.

The Centers for Disease Control and Prevention director, Rochelle Walensky, issued a statement late Thursday advising that booster shots could be given to people with the Pfizer vaccine 6 months after the second of their first two shots. 

Her statement broadened eligibility for the shots beyond the recommendations of a CDC advisory panel and the Food and Drug Administration, which authorized Pfizer boosters last week. But Biden said Walensky was in-line with medical science.


“The decision of which booster shot to give, when to start the shot, and who will get them, is left to the scientists and the doctors,” Biden said. “That’s what happened here.”

In particular, Walensky said that people age 18 to 64, who have no underlying medical conditions but who work in places with a high chance of Covid-19 exposure, would be able to get a shot.

She also opened eligibility to those 65 and up and those age 50 to 64 with underlying medical conditions, saying both groups should get a booster.

And she said people age 18 to 49 with underlying medical conditions could get a booster “based on their individual benefits and risks” without saying whether they should get a third shot. 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Joe BidenCoronavirusPfizerCoronavirus Vaccine

Next Story